NFE2L2 and prostate carcinoma: In prostate cancer, Panx2 facilitated tumor cell proliferation, migration and invasion via ferroptosis and Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) signaling pathway (Liao et al., 2020).